Fernández-Del-Río Lucía, Nag Anish, Gutiérrez Casado Elena, Ariza Julia, Awad Agape M, Joseph Akil I, Kwon Ohyun, Verdin Eric, de Cabo Rafael, Schneider Claus, Torres Jorge Z, Burón María I, Clarke Catherine F, Villalba José M
Departamento de Biología Celular, Fisiología e Inmunología, Universidad de Córdoba, Campus de Excelencia Internacional Agroalimentario, ceiA3, Spain.
Department of Chemistry and Biochemistry and the Molecular Biology Institute, UCLA, Los Angeles, CA, USA.
Free Radic Biol Med. 2017 Sep;110:176-187. doi: 10.1016/j.freeradbiomed.2017.06.006. Epub 2017 Jun 9.
Coenzyme Q (Q) is a lipid-soluble antioxidant essential in cellular physiology. Patients with Q deficiencies, with few exceptions, seldom respond to treatment. Current therapies rely on dietary supplementation with Q, but due to its highly lipophilic nature, Q is difficult to absorb by tissues and cells. Plant polyphenols, present in the human diet, are redox active and modulate numerous cellular pathways. In the present study, we tested whether treatment with polyphenols affected the content or biosynthesis of Q. Mouse kidney proximal tubule epithelial (Tkpts) cells and human embryonic kidney cells 293 (HEK 293) were treated with several types of polyphenols, and kaempferol produced the largest increase in Q levels. Experiments with stable isotope C-labeled kaempferol demonstrated a previously unrecognized role of kaempferol as an aromatic ring precursor in Q biosynthesis. Investigations of the structure-function relationship of related flavonols showed the importance of two hydroxyl groups, located at C3 of the C ring and C4' of the B ring, both present in kaempferol, as important determinants of kaempferol as a Q biosynthetic precursor. Concurrently, through a mechanism not related to the enhancement of Q biosynthesis, kaempferol also augmented mitochondrial localization of Sirt3. The role of kaempferol as a precursor that increases Q levels, combined with its ability to upregulate Sirt3, identify kaempferol as a potential candidate in the design of interventions aimed on increasing endogenous Q biosynthesis, particularly in kidney.
辅酶Q(Q)是细胞生理学中必需的脂溶性抗氧化剂。除少数例外,Q缺乏症患者很少对治疗有反应。目前的治疗方法依赖于饮食中补充Q,但由于其高度亲脂性,Q很难被组织和细胞吸收。人类饮食中存在的植物多酚具有氧化还原活性,并能调节多种细胞途径。在本研究中,我们测试了多酚处理是否会影响Q的含量或生物合成。用几种类型的多酚处理小鼠肾近端小管上皮(Tkpts)细胞和人胚肾细胞293(HEK 293),山奈酚使Q水平升高幅度最大。用稳定同位素C标记的山奈酚进行的实验表明,山奈酚在Q生物合成中作为芳香环前体具有以前未被认识的作用。对相关黄酮醇结构-功能关系的研究表明,位于C环的C3和B环的C4'上的两个羟基很重要,这两个羟基都存在于山奈酚中,是山奈酚作为Q生物合成前体的重要决定因素。同时,通过一种与增强Q生物合成无关的机制,山奈酚还增强了Sirt3的线粒体定位。山奈酚作为增加Q水平的前体的作用,与其上调Sirt3的能力相结合,确定山奈酚是旨在增加内源性Q生物合成的干预措施设计中的潜在候选物,特别是在肾脏中。